Emorfazone

Emorfazone

SCHEMBL1162007

CC(C)(CO)NCC(O)c1ccccc1.CCOc1c(N2CCOCC2)cnn(C)c1=O

nearest known ligand 0.39

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.39
▸ GAA P10253 1/20 0.39
▸ BRD4 O60885 2/20 0.39
▸ BRD9 Q9H8M2 2/20 0.39
▸ SYK P43405 1/20 0.39
▸ ITGB1 P05556 1/20 0.38
▸ ITGA4 P13612 1/20 0.38
▸ ITGB7 P26010 1/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ L3MBTL1 Q9Y468 1/20 0.38
▸ KCNQ2 O43526 1/20 0.37
▸ PTGS1 P23219 1/20 0.37
▸ ATM Q13315 1/20 0.36
▸ LMNA P02545 3/20 0.35
▸ CTSL P07711 2/20 0.35
▸ CTSB P07858 2/20 0.35
▸ CTSS P25774 2/20 0.35
▸ CTSK P43235 2/20 0.35
▸ HCAR1 Q9BXC0 1/20 0.35
▸ HSD17B10 Q99714 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Emorfazone SCHEMBL26203 0.78 BRD4 (0.46) ALDH1A1GAABRD4BRD9ITGB1
Fepradinol SCHEMBL151235 0.68 KDM4E (0.55) ALDH1A1SMN1; SMN2L3MBTL1LMNA
Fepradinol SCHEMBL29454386 0.67 KDM4E (0.53) ALDH1A1L3MBTL1LMNA
Fepradinol SCHEMBL1649187 0.66 KDM4E (0.52) ALDH1A1SMN1; SMN2L3MBTL1LMNA
Metamizole SCHEMBL5644145 0.65 KDM4E (0.60) ALDH1A1BRD4BRD9SMN1; SMN2PTGS1
SCHEMBL22001230 0.58 KDM4E (0.52) ALDH1A1SMN1; SMN2L3MBTL1LMNA
SCHEMBL18394752 0.58 L3MBTL1 (0.52) ALDH1A1SMN1; SMN2L3MBTL1LMNAHSD17B10
SCHEMBL2555460 0.57 BRD4 (0.46) ALDH1A1GAABRD4BRD9ITGB1
SCHEMBL10784774 0.57 ADRB3 (0.47) ALDH1A1GAASMN1; SMN2L3MBTL1
SCHEMBL18412809 0.57 KMT2A (0.48) ALDH1A1BRD4BRD9SMN1; SMN2L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011017294-A1 HUMAN ANTI-RANKL ANTIBODIES SCHERING CORPORATION (US) 2011-02-10 — — WO disclosed
Send feedback